FERN KUMAR: Open Payments
NPI 1992729396 · WINCHESTER, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,245 in 48 payments from 14 companies in 2025. Trend: 2023 $20 · 2024 $637 · 2025 $1,245
Food & beverage: $1,245
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $414 |
| AstraZeneca Pharmaceuticals LP | 10 | $185 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $132 |
| ABBVIE INC. | 4 | $90 |
| Boston Scientific Corporation | 1 | $77 |
| Merck Sharp & Dohme LLC | 3 | $69 |
| Amgen Inc. | 4 | $67 |
| PFIZER INC. | 3 | $63 |
| Medtronic, Inc. | 1 | $31 |
| Kowa Pharmaceuticals America, Inc. | 2 | $31 |
Products named: Wegovy, Kerendia, Ozempic, BREZTRI, ENROUTE Transcarotid Neuroprotection System, GARDASIL 9, AIRSUPRA, VRAYLAR.
Industry payments across VA — which companies pay providers there.
